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bacteria
E. Vanlaere, P. Vandamme. Laboratorium voor Microbiologie, Universiteit Gent,
B-9000 Gent, Belgium
Burkholderia cepacia complex (BCC) organisms are important cystic ﬁbrosis (CF)
pathogens with a considerable inﬂuence on morbidity and mortality. Presently, nine
BCC species have been described but ongoing collaborative studies recently re-
vealed the existence of at least another 6 new BCC species occurring in CF samples.
Identiﬁcation of all of these BCC species is a complicated challenge requiring a
combination of multiple molecular diagnostic procedures and is mostly restricted
to reference centers.
The algorithm used for the identiﬁcation of BCC isolates in our reference center
is outlined and is applied to examine a number of BCC isolates representing
several additional BCC bacteria not belonging to one of the established species.
An overview of current identiﬁcation approaches for BCC bacteria is presented.
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Cepacia Syndrome is a rapidly progressive and usually fatal pneumonia mostly
due to infection with Bcc genomovars III or II. It is characterised by a rapidly
progressive respiratory illness, pyrexia, elevated leukocyte count, progressive and
conﬂuent CXR changes and positive blood cultures.
A 10 year old girl presented with a respiratory exacerbation in May 2006.
Sputum had previously grown Alcaligenes spp. Due to multiple severe allergies
she was desensitised to ceftazidime and began a 2 week course of IV ceftazidime
and tobramycin. She responded to treatment with an improvement in RFTs and
symptoms. Sputum on this admission grew Burkholderia cenocepacia IIIA. She had
a further respiratory exacerbation in August and the same organism was re-cultured
from sputum. For this episode she was treated with IV tigecycline. In November
she presented with an increase in cough, weight loss, profound lethargy, SpO2
of 92%, generalised coarse crackles and pyrexia of 40ºC. Investigations revealed
neutrophils 17.3, CRP 121 and new bilateral inﬁltrates on CXR. Bc. Gv IIIA was
isolated in sputum and blood cultures. Treatment included prednisolone 40mg daily
and IV tobramycin, meropenem and ceftazidime. Six days into treatment she began
to improve. She completed 21 days of IV antibiotics and steroids. She continues
with a productive cough and increased requirement for intermittent IV antibiotics.
There are very few reports of patients surviving cepacia syndrome. The early use of
steroids may have contributed to survival by reducing the inﬂux of proinﬂammatory
cytokines and neutrophil induced inﬂammation associated with cepacia syndrome.
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Monitoring of respiratory infection, identiﬁcation of morphotypes of Pa and chronic
infection evaluation are important to determine prognosis and choose the treatment.
To describe the situation of Pa respiratory infection and evaluate the chronic
colonization.
The study was made in a pediatric reference center for CF and involved 116 patients.
Respiratory cultures collected between Jan-Dec 2006 were included. Sex, age,
number of exams/patient/year, cultures positivity, number of patients with positive
cultures to Pa, bacteria morphologic types, and chronic colonization criteria were
observed. Data related to frequency were analyzed.
There were a prevalence of 55% in females, the mean age was 9 yo and 10mo
and median age: 9 yo and 5mo (min 11, max 264mo). 455 cultures of respiratory
secretion were made, with average of 3.92 cultures/patient/year. The vast majority
of this cultures were positive: 348/455 (76.5%). From 116 children and teens with
CF, 66 (57%)were positive to Pa, in which 42 (63.6%) made 4 or more cultures/year
and therefore were evaluated about chronic colonization (CC): 20/42 (47.6%) – yes.
The median age in this group was 8 yo and 4mo. In the group of children that were
positive to Pa, 17/66 (25.7%) showed only non-mucoid morphotype, 20/66 (30.3%),
mucoid and 29/66 (44%), both of them.
The early isolation of Pa, the high prevalence of mucoid morphotype and chronic
colonization show the severity of the disease in this group of pediatric patients.
These considerations reassure the importance of including CF in the investigation
of respiratory disorders. Microbiology aspects should be correlated to image
and functional presentation and therefore contribute to treatment approach and
prognosis.
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Introduction: Longitudinal studies have shown that patients with CF may harbour
more than one strain of P. aeruginosa, but few studies have examined multiple
colonies from single sputum samples. We aimed to study the diversity, according
to genotype, of P. aeruginosa in single sputum samples.
Methods: Sputum samples from 16 patients with CF, infected with P. aeruginosa
for at least 12 months, were treated with sputasol then serially diluted and incubated
for 12hr at 37ºC on the following agar plates: BHI agar, P. aeruginosa isolation
agar (PIA), and PIA with ciproﬂoxacin (2mg/l), ceftazidime (8mg/l), tobramycin
(8mg/l), and colistin (4mg/l). 47 colonies from each sputum were picked from
the overnight culture, including representatives from each antibiotic plate and each
morphotype. The colonies were typed using multilocus sequence typing (MLST).
Results: Demographics were: 9 were male, mean age 28.3 yr, mean FEV1 49.8%
predicted. Full MLST data were obtained for 6−39 colonies (mean 26.8) per sample.
8 patients had only 1 genotype, 6 had 2 genotypes, 1 had 3 genotypes, and 1 had
4 genotypes. In 4 patients different morphotypes were associated with different
genotypes, in 1 patient mucoid and non-mucoid colonies had different genotypes,
and in 5 patients particular antibiotics selected for particular genotypes. Overall
50% of patients harboured more than one strain, which was similar to results from
studies testing fewer colonies with PFGE or RAPD genotyping.
Conclusions: In the ﬁrst study to genotype more than 12 colonies per sputum
sample or use MLST, we found that patients harboured between one to four strains
and 50% of patients harboured more than one strain.
